Product Images Erlotinib Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Erlotinib Hydrochloride NDC 46708-567 by Alembic Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

30 tablets - erlotinib 100

30 tablets - erlotinib 100

Each film-coated tablet contains 100mg of erlotinib free base. The usual dosage is available in the enclosed package insert. The tablets should be stored at 25°C with excursions permitted to 15° to 30°C. The package is child-resistant. The manufacturer is Alembic Pharmaceuticals Limited located in Gujarat, India. The product is Erlotinib Tablets with NDC number 46708-566-30. The remaining text is not decipherable.*

30 tablets - erlotinib 150

30 tablets - erlotinib 150

Each tablet contains 150mg of erlotinib free base. Please see the enclosed package insert for complete prescribing information including the usual dosage. The package is child-resistant and must be stored at a temperature between 15°C to 30°C. Manufactured by Alembic Pharmaceuticals in Gujarat, India, the package contains 30 tablets of Erlotinib. The lot number and expiry date are not available.*

30 tablets - erlotinib 25

30 tablets - erlotinib 25

Each film-coated tablet of Erlotinib contains 25mg of erlotinib free base. See enclosed package insert for dosage and complete prescribing information. The tablets should be stored at 25°C (77°F), with excursions permitted between 15° to 30°C (59° to 86°F) as guided by USP Controlled Room Temperature. The manufacturer of Erlotinib tablets is Alembic Pharmaceuticals Limited, located at Survey No. 84, 87 and 88, Panelav, Taluka Halol, Panchmahal, Gujarat 389350, India. The tablets are available in a pack of 30, with a National Drug Code (NDC) of 46708-565-30 labeled with "Rxonly." The Lot number and EXP date are not available.*

figure1 - erlotinib figure1

figure1 - erlotinib figure1

Figure 2 - erlotinib figure2

Figure 2 - erlotinib figure2

Figure 3 - erlotinib figure3

Figure 3 - erlotinib figure3

This appears to be a partial table with survival probabilities and number of patients at risk for two treatments (placebo and erlotinib) and different time periods. The table provides information on overall survival in months for the two treatments.*

figure4 - erlotinib figure4

figure4 - erlotinib figure4

Structure - erlotinib str2

Structure - erlotinib str2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.